Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28272681)

  • 1. Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features.
    Venkatachala S; Rajendran M
    Turk Patoloji Derg; 2017; 33(3):228-234. PubMed ID: 28272681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of COX-2 and HER-2 in colorectal cancer and their correlation.
    Wu QB; Sun GP
    World J Gastroenterol; 2015 May; 21(20):6206-14. PubMed ID: 26034355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
    Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
    Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
    Karahan B; Argon A; Yıldırım M; Vardar E
    Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between inducible nitric oxide synthase and cyclooxygenase-2 expression in human colorectal adenocarcinoma: a cross-sectional study.
    Habibollahi P; Jamshidiha M; Daryani NE; Jahanzad I; Ghahremani MH; Ostad SN
    Pathol Oncol Res; 2010 Sep; 16(3):327-35. PubMed ID: 20069397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
    Yao HB; Wu AG; Chen YJ; Tang BH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
    Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
    Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of 5-lipoxygenase expression and clinicopathological factors in colorectal carcinoma].
    Li YC; Wang DX; Li CS; Ye ZP; Wu ZM; Chen JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):895-7. PubMed ID: 24062003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
    Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
    Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
    Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
    Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
    Zhang H; Sun XF
    Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas.
    Okayasu I; Mitomi H; Yamashita K; Mikami T; Fujiwara M; Kato M; Oshimura M
    J Cancer Res Clin Oncol; 1998; 124(8):444-9. PubMed ID: 9750021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
    Yuan H; Tu SL; He XJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of COX-2 expression in patients with colorectal cancer.
    Yamac D; Celenkoglu G; Coskun U; Akyurek N; Akcali Z; Dursun A; Koybasioglu F
    Pathol Res Pract; 2005; 201(7):497-502. PubMed ID: 16164044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix.
    Kang S; Kim MH; Park IA; Kim JW; Park NH; Kang D; Yoo KY; Kang SB; Lee HP; Song YS
    Cancer Lett; 2006 Jun; 237(2):305-11. PubMed ID: 16111807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
    Lam AK; Ong K; Ho YH
    Hum Pathol; 2008 Apr; 39(4):599-604. PubMed ID: 18284933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.